Yaz: Defective Drug Attorney
Yaz Lawsuit Side Effects : Blood Clots, Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Venous Thromboembolism (VTE) Heart attacks, Strokes
Other potential Yaz Side Effects: Blood Clots, Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Venous Thromboembolism (VTE) Heart attacks, Strokes, Death
The leading law firm of Alonso Krangle LLP is currently investigating potential Yaz lawsuits on behalf of young women and their families who believe their use of either the Yaz or Yasmin birth control pill caused them to suffer a dangerous blood clot or other serious Yaz side effect. A number of studies have linked drospirenone, the synthetic progestin found in Yaz birth control, with life-threatening blood clots, heart attacks and strokes. It is believed that dozens of young women may have died as a result of these Yaz side effects injuries. Yaz side effects currently being investigated by our defective drug lawyers include:
- Heart attack
- Blood clots
- Deep vein thrombosis (DVT)
- Pulmonary embolism (PE)
For more on Yasmin Side Effects and the Yasmin Lawsuit, click on a link.
The defective drug lawyers at Alonso Krangle LLP rank among the nation’s top personal injury lawyers, and are committed to making sure the victim of Yaz side effects receive the justice they deserve. If you or a loved one suffered a serious blood clot, heart attack, stroke, or other serious Yaz side effect injury, you deserve to be compensated for your pain and suffering. By filing a Yaz lawsuit, you may be able to obtain restitution from Bayer AG and other makers of these contraceptives for your medical bills, lost wages, and emotional distress. If a young woman you loved died because of a Yaz side effect, you may be entitled to damages for wrongful death. The defective drug lawyers at Alonso Krangle LLP are currently offering free Yaz lawsuit consultations to anyone injured by Yaz. To learn more about your legal rights, please contact the Yaz and Yasmin lawyers at Alonso Krangle LLP today.
The Dangers of Yaz Side Effects
Yaz contains a combination of the synthetic progestin, drospirenone, and ethinyl estradiol, an estrogen. Yasmin was approved by the U.S. Food Drug Administration (FDA) in 2001 for the prevention of pregnancy in women who elect to use an oral contraceptive. Yaz, which was cleared by the FDA in 2006, is approved to prevent pregnancy, and treat premenstrual dysphoric disorder (PMDD) and certain types of moderate acne in women.
Drospirenone, known as a “fourth-generation” progestin, can elevate the body’s potassium levels, which can lead to a condition called hyperkalemia in certain patients. Hyperkalemia can cause a number of complications, including heart arrhythmias and cardiac arrest. Yaz and Yasmin are not considered safe for women with liver problems, kidney issues, or adrenal disease. In order for users of these contraceptives to avoid serious complications, they should have the potassium levels in their blood checked every few months.
Since 2009 a total of five large studies have found evidence that drospirenone birth control pills pose a higher risk of blood clots compared to those containing an older form of progestin. Only two large studies, both funded by the maker of Yaz and Yasmin, have failed to find an increased risk. In May 2011, the FDA announced it had launched a safety review of Yaz, Yasmin and similar pills after two studies published in The British Medical Journal reported a two- to three-fold greater risk of blood clots – including life threatening DVT and PE – among women who took drospirenone pills compared those who took oral contraceptives made levonorgestrel, an older progestin. Because other studies had produced conflicting findings, the FDA decided to conduct a comprehensive review of the drugs’ blood clot dangers.
In an update issued in September 2011, the FDA announced its review of early results of an agency-funded study suggested that women who use Yaz, Yasmin and other oral contraceptives made with drospirenone could face a 1.5-fold increase in the risk of blood clots compared to those who take other pills. In its Drug Safety Communication, the FDA said it “remains concerned, about the potential increased risk of blood clots with the use of drospirenone-containing birth control pills.”
The FDA’s findings prompted it to convene a joint meeting of its Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to review the evidence linking Yaz and Yasmin to dangerous blood clots and issue recommendations to the agency. On December 8, 2011, the committees voted 21-5 that the current information contained on the drugs’ labels regarding blood clot risks is inadequate and should be updated. In a much closer vote (15 to 11), the FDA advisors recommended that Yaz and Yasmin should remain on the market.
Misleading Yaz and Yasmin Advertising
The manufacturers of Yaz and Yasmin have been in trouble with the FDA on at least two occasions for running TV commercials for the birth control bills that the agency found to be misleading. In 2003, the FDA issued a warning letter to Berlex Laboratories, now a subsidiary of Bayer, after the agency found that a television ad for Yasmin titled “Goodbye Kiss” “misleadingly represents or suggests that Yasmin is safer than has been demonstrated by substantial evidence or substantial clinical experience.” The FDA also noted that women and their healthcare providers must weigh Yasmin’s additional health risks when considering Yasmin over [oral contraceptives] without drospirenone.
In October 2008, the FDA issued Bayer Pharmaceuticals a warning letter for making deceptive claims in two Yaz TV commercials, known as the “We’re Not Gonna Take It” and “Balloon” ads. According to the letter, the advertising overstated the benefits of Yaz and downplayed serious Yaz side effects, including potentially life-threatening blood clots. The questionable ads also prompted 27 state attorneys general to file suit against Bayer, which was forced pull the Yaz ads and run a corrective campaign in February 2009.
Learn More About Filing A Yaz Lawsuit
If you or a young woman suffered a Yaz blood clot, DVT, PE, heart attack, or stroke, and you believe Yaz side effect is to blame, you may be eligible to file a Yaz lawsuit against Bayer and other manufacturers of these birth control pills. To learn more about the legal options available to you, please contact the Yaz lawyers at Alonso Krangle LLP by filling out our online form or calling us.
Excellent and fast 100% recommended to me in a matter of 7 months my request came out they are very good they treated me very well everyone thank you very much.
(Original) Excellent y rápido 100% recomendado a my en cuestión de 7 meses me salió mi demanda son muy buenos me trataron muy bien todos muchas gracias.